Effectiveness of Folic Acid Supplementation in Acute Watery Diarrhea Among Children Under 5 Years of Age

Last updated: May 12, 2022
Sponsor: King Edward Medical University
Overall Status: Active - Recruiting

Phase

4

Condition

Lactose Intolerance

Colic

Bowel Dysfunction

Treatment

N/A

Clinical Study ID

NCT04782037
321/RC/KEMU
  • Ages 2-5
  • All Genders

Study Summary

Folic acid is a palatable and easily available drug with no serious adverse effects. L-methylfolate is its biologically activated form and is preferred because of its direct availability for certain metabolic processes. As there is no specific and safe drug available that may help in decreasing the duration of diarrhea, purging rate or consistency of stools; and having known the theoretical benefits of folic acid in this regard, it would be appropriate to assess the effectiveness of L-methylfolate among children with diarrhea.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Children aged 2months- 5 years
  • Both genders
  • Acute watery diarrhea as per operational definition
  • Diarrhea of less than 7-day duration

Exclusion

Exclusion Criteria:

  • Severely malnourished children <3 SD
  • Bloody diarrhea
  • Prolonged (7-14 days duration), persistent (>14 days duration) or chronic diarrhea (>4weeks duration)
  • Those who received folic acid within the last 14 days
  • Hospital-acquired diarrhea (diarrhea occurring after 48hrs of stay in hospital)
  • Antibiotic-associated diarrhea.
  • Presence of other co morbid conditions like pneumonia, sepsis, meningitis, etc.

Study Design

Total Participants: 324
Study Start date:
October 21, 2020
Estimated Completion Date:
July 01, 2022

Study Description

After approval from the Institutional Review Board of King Edward Medical University, Mayo Hospital, Lahore, all children diagnosed with acute watery diarrhea as per operational definition fulfilling the inclusion criteria, presenting to the Department of Pediatrics, Mayo Hospital, will be enrolled in this study.

Informed written consent will be taken from the parents/guardians of all participants. A detailed history and examination of each subject would be done by an investigator at presentation.

Patients will be randomized in two groups - A and B by lottery method. There will be 162 patients in each group. The treatment regimen that includes breast feeding, nutritional advice, rehydration plan; ORT by low osmolar ORS or intravenous rehydration (if required) and zinc sulphate will be given according to the WHO guidelines to all patients of both groups. Children under 1 year of age in group A will receive 3 drops (90mcg) of L-methylfolate calcium) while those older than 1 year of age will be given 5 drops (150mcg). Subjects in Group B will receive equal amount of distilled water as placebo (i.e. 3 drops to <1yr age and 5 drops to >1 yr. Frequency and grades of loose stools in both groups will be assessed daily and written down on a predesigned proforma.

Connect with a study center

  • Mayo hospital

    Lahore, Punjab 56000
    Pakistan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.